{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:39:44Z","timestamp":1785465584129,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.089","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T19:18:48Z","timestamp":1313522328000},"page":"7307-7319","source":"Crossref","is-referenced-by-count":67,"title":["Prevention of tick-borne encephalitis by FSME-IMMUN\u00ae vaccines: Review of a clinical development programme"],"prefix":"10.1016","volume":"29","author":[{"given":"Alexandra","family":"Loew-Baselli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Poellabauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borislava G.","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandor","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Petermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Noel","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut J.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.07.089_bib0005","series-title":"Vaccines","first-page":"841","article-title":"Tick-borne encephalitis virus vaccines","author":"Barrett","year":"2008"},{"issue":"33","key":"10.1016\/j.vaccine.2011.07.089_bib0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1438-4221(02)80010-8","article-title":"Occurrence of TBE in areas previously considered being non-endemic: scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW-TBE)","volume":"291","author":"Haglund","year":"2002","journal-title":"Int J Med Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.07.089_bib0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00023210-200519120-00004","article-title":"Tick-borne encephalopathies: epidemiology, diagnosis, treatment and prevention","volume":"19","author":"Gunther","year":"2005","journal-title":"CNS Drugs"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2011.07.089_bib0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10354-010-0758-5","article-title":"Tick-borne Encephalitis and golden agers: position paper of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE)","volume":"160","author":"Jelenik","year":"2010","journal-title":"Wien Med Wochenschr"},{"issue":"43","key":"10.1016\/j.vaccine.2011.07.089_bib0025","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.089_bib0030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2006.07.026","article-title":"Study of the serological response after vaccination against tick-borne encephalitis in Sweden","volume":"25","author":"Vene","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.089_bib0035","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Linquist","year":"2008","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.07.089_bib0040","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.089_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jmv.1890060304","article-title":"Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultra-centrifugation","volume":"6","author":"Heinz","year":"1980","journal-title":"J Med Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.07.089_bib0050","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0264-410X(02)00814-9","article-title":"History of TBE vaccines","volume":"21","author":"Barrett","year":"2003","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2011.07.089_bib0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0264-410X(01)00329-2","article-title":"Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination","volume":"20","author":"Marth","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.089_bib0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(03)00563-2","article-title":"Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity","volume":"22","author":"Ehrlich","year":"2003","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2011.07.089_bib0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0264-410X(02)00593-5","article-title":"Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN \u201cNEW\u201d in children: results of post-marketing surveillance","volume":"21","author":"Pavlova","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.089_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/CDLI.5.1.105-113.1998","article-title":"Immune function in healthy adolescents","volume":"5","author":"Bartlett","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.089_bib0075","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CDLI.8.4.740-746.2001","article-title":"Immune function in healthy inner-city children","volume":"8","author":"Bartlett","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Suppl. 37","key":"10.1016\/j.vaccine.2011.07.089_bib0080","first-page":"126","article-title":"Randomized, phase II, multicenter dose-finding studies of a modified tick-borne encephalitis vaccine in children: evaluation of safety and immunogenicity of two vaccinations with FSME-Immun\u00ae \u201cnew\u201d","volume":"293","author":"Ehrlich","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"29","key":"10.1016\/j.vaccine.2011.07.089_bib0085","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1016\/j.vaccine.2010.04.075","article-title":"Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine","volume":"28","author":"P\u00f6llabauer","year":"2010","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2011.07.089_bib0090","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.vaccine.2006.03.061","article-title":"Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN\u00ae: results of two large phase 3 clinical studies","volume":"24","author":"Loew-Baselli","year":"2006","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2011.07.089_bib0095","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2011.07.089_bib0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10354-005-0178-0","article-title":"The golden agers and tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on tick-borne encephalitis","volume":"155","author":"Kunze","year":"2005","journal-title":"Wien Med Wochenschr"},{"issue":"7","key":"10.1016\/j.vaccine.2011.07.089_bib0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712590903066711","article-title":"Serological response to tick-borne encephalitis (TBE) vaccination in the elderly\u2014results from an observational study","volume":"9","author":"Jilkova","year":"2009","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2011.07.089_bib0110","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2008.10.003","article-title":"Antibody response following administration of two paediatric tickborne encephalitis vaccines using two different vaccination schedules","volume":"27","author":"Wittermann","year":"2009","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2011.07.089_bib0115","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1016\/j.vaccine.2010.04.047","article-title":"Comparison of immunogenicity and safety between two paediatric TBE vaccines","volume":"28","author":"P\u00f6llabauer","year":"2010","journal-title":"Vaccine"},{"issue":"September (Suppl. 1)","key":"10.1016\/j.vaccine.2011.07.089_bib0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijmm.2008.01.002","article-title":"Paediatric tick-borne encephalitis (TBE) vaccines: schedules to optimize protection","volume":"298","author":"Wittermann","year":"2008","journal-title":"Int J Med Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.07.089_bib0125","first-page":"213","article-title":"Immunogenicity and safety of FSME-IMMUN 0.5ml using a rapid immunisation schedule","volume":"296","author":"Loew-Baselli","year":"2006","journal-title":"Int J Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.089_bib0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4161\/hv.5.8.8571","article-title":"Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN\u00ae 0.5ml in adults aged 18\u201367 years","volume":"5","author":"Loew-Baselli","year":"2009","journal-title":"Hum Vaccin"},{"issue":"20","key":"10.1016\/j.vaccine.2011.07.089_bib0135","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.vaccine.2010.03.024","article-title":"Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50\u201390 years","volume":"28","author":"Weinberger","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.089_bib0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vaccine.2004.07.002","article-title":"Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation","volume":"23","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2011.07.089_bib0145","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.vaccine.2004.01.041","article-title":"Persistence of protective immunity following vaccination against tick-borne encephalitis\u2014longer than expected?","volume":"22","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.089_bib0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s15010-002-2020-6","article-title":"Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis","volume":"31","author":"Panasiuk","year":"2003","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.089_bib0155","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2141.1992.tb06432.x","article-title":"Cellular and humoral immune responses in haemophiliacs after vaccination against tick-borne encephalitis","volume":"82","author":"Wolf","year":"1992","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.089_bib0160","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/1097-0142(19861015)58:8<1648::AID-CNCR2820580812>3.0.CO;2-E","article-title":"Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy","volume":"58","author":"Zielinski","year":"1986","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.089_bib0165","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.vaccine.2007.11.074","article-title":"Diminished response to tick-borne encephalitis vaccination in thymectomized children","volume":"26","author":"Prelog","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.07.089_bib0170","first-page":"358","article-title":"Shortening of interval between first and second TBE vaccination in asthmatic children","volume":"93","author":"Hofmann","year":"1981","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.089_bib0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.07.089_bib0180","first-page":"201","article-title":"Tick-borne encephalitis and the impact of vaccination","volume":"18","author":"Heinz","year":"2004","journal-title":"Arch Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.07.089_bib0185","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1128\/JCM.42.9.4101-4110.2004","article-title":"Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses","volume":"42","author":"Holbrook","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.07.089_bib0190","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3201\/eid1210.060320","article-title":"Siberian subtype tick-borne encephalitis virus, Finland","volume":"12","author":"J\u00e4\u00e4skel\u00e4inen","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.089_bib0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0264-410X(92)90376-U","article-title":"Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes","volume":"10","author":"Holzmann","year":"1992","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2011.07.089_bib0200","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0264-410X(98)00360-0","article-title":"Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization","volume":"17","author":"Chiba","year":"1999","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2011.07.089_bib0205","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1016\/S0264-410X(01)00218-3","article-title":"Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains","volume":"19","author":"Hayasaka","year":"2001","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2011.07.089_bib0210","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.vaccine.2009.02.069","article-title":"Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human","volume":"27","author":"Leonova","year":"2009","journal-title":"Vaccine"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.07.089_bib0215","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/infdis\/jir122","article-title":"A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans","volume":"203","author":"Orlinger","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.089_bib0220","series-title":"Janeway's immunobiology","author":"Murphy","year":"2008"},{"issue":"Suppl. 37","key":"10.1016\/j.vaccine.2011.07.089_bib0225","first-page":"139","article-title":"Stimulation of the immune system by different TBE-virus vaccines","volume":"293","author":"Marth","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.07.089_bib0230","first-page":"319","article-title":"Post-marketing surveillance study on the safety of a vaccine for tick-borne encephalitis","volume":"75","author":"Satz","year":"2005","journal-title":"Hospitalis"},{"issue":"7\/8","key":"10.1016\/j.vaccine.2011.07.089_bib0235","first-page":"319","article-title":"The safety of a TBE-vaccine in children: a post-marketing surveillance study in Switzerland","volume":"75","author":"Satz","year":"2005","journal-title":"Hospitalis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.07.089_bib0240","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0264-410X(02)00815-0","article-title":"A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis","volume":"21","author":"Baumhackl","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.07.089_bib0245","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00415-004-0329-z","article-title":"Two severe cases of tick-borne encephalitis despite complete active vaccination\u2014the significance of neutralizing antibodies","volume":"251","author":"Bender","year":"2004","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.07.089_bib0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.vaccine.2007.11.009","article-title":"TBE infection in an incomplete immunized person at-risk who lives in a high endemic area\u2014impact on current recommendations for immunization of high-risk groups","volume":"26","author":"Plisek","year":"2008","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2011.07.089_bib0255","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T09:38:53Z","timestamp":1592818733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1101139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":51,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X1101139X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}